Guatemala

Reimbursed Care Access

Guatemala maintains a restrictive national narcotics framework (Decreto No. 48-92) that broadly criminalizes controlled psychotropic substances and provides for tight state control; routinely this means licensed medical use is limited to recognized pharmaceuticals used in hospitals, while classical psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X, ibogaine, ayahuasca) have no routine medical reimbursement or authorized outpatient medical programs and are only encountered in research/gray‑zone settings or strictly prohibited. Ketamine is used in clinical anesthesia and is available through public hospital procurement and private clinics (including private, off‑label mental‑health clinics), but esketamine (Spravato) has no readily available public registration or reimbursed program in Guatemala as of public sources checked.